Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Plunges 4%; BSE HEALTHCARE Index Up 0.2%
Mon, 14 Oct 13:43

ALEMBIC PHARMA Plunges 4%; BSE HEALTHCARE Index Up 0.2%Image source: KanawatTH/www.istockphoto.com

ALEMBIC PHARMA share price has plunged 4% and is presently trading at Rs 1,122.3.

Meanwhile, the BSE HEALTHCARE index is at 44,523.3 (up 0.2%).

Among the top losers in the BSE HEALTHCARE index today are AJANTA PHARMA (down 2.8%) and ASTRAZENECA PHARMA (down 2.2%).

HIKAL CHEMIC (up 6.5%) and POLY MEDICURE (up 4.2%) are among the top gainers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 766.7 to Rs 1,122.3, registering a gain of Rs 355.6 (up 46.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,004.5 to 44,523.3, registering a gain of 59.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 175.0%), Glenmark Pharma (up 131.4%) and SUVEN PHARMACEUTICALS (up 115.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,972.5 (up 0.7%).

The top gainers among the BSE Sensex today are Tech Mahindra (up 2.7%) and L&T (up 2.4%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 25,117.8 (up 0.6%). Wipro and Tech Mahindra are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,079.4 to 81,972.5, registering a gain of 15,893.2 points (up 24.1%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit grew 11.3% YoY to Rs 1,342 million for the quarter ended June 2024, compared to a profit of Rs 1,206 million a year ago. Net sales rose 5.1% to Rs 15,617 million during the period as against Rs 14,862 million in April-June 2023.

For the year ended March 2024, ALEMBIC PHARMA reported 80.1% increase in net profit to Rs 6,158 million compared to net profit of Rs 3,420 million during FY23. Revenue of the company grew 10.2% to Rs 62,286 million during FY24.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 35.0.


Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Plunges 4%; BSE HEALTHCARE Index Up 0.2%". Click here!